CROSS-BORDER MERGERS AND ACQUISITIONS IN THE INDIAN PHARMACEUTICAL INDUSTRY UNDER THE COMPETITION ACT, 2002

AUTHOR – DIKSHA RAO, STUDENT CHRIST (DEEMED TO BE UNIVERSITY), PUNE LAVASA CAMPUS

BEST CITATION – DIKSHA RAO, CROSS-BORDER MERGERS AND ACQUISITIONS IN THE INDIAN PHARMACEUTICAL INDUSTRY UNDER THE COMPETITION ACT, 2002, INDIAN JOURNAL OF LEGAL REVIEW (IJLR), 6 (8) OF 2026, PG. 541-547, APIS – 3920 – 0001 & ISSN – 2583-2344.

Abstract

Corporations choose mergers and acquisitions to boost growth and differentiate themselves from competitors. M&As contribute to increased client numbers, market and segment expansion, technological advancement, and cost savings. In 1991, economic reforms began, and as a result of globalisation, economies began to integrate. It was believed that, as a result of globalisation, foreign businesses would destroy Indian markets by purchasing Indian corporations. However, cooperation between Indian and foreign businesses has made it possible for both parties to benefit. These days, Indian businesses are expanding overseas and purchasing foreign companies, demonstrating their value and worth.

Following the period of economic reforms and post-globalisation, Indian businesses have been expanding in the face of both new market opportunities and obstacles. The presence of foreign multinational corporations (MNCs), the evolving global economic climate, the awakening of customers, and the shifting political landscape all put pressure on the enterprises. By investing in tactics that enable them to accomplish these particular aims, corporates are encouraged to seek and broaden the market for their products and to increase their client base.

FMCG, telecommunication, healthcare, textiles, finance, and pharmaceuticals are some of the main industries where M&As are prevalent. Pharmaceuticals are one of these industries that are always growing in the Indian market. The goal and benefits of mergers and acquisitions are being investigated in this study.
The Indian market by examining the results of two corporate categories. The companies in India’s pharmaceutical industry that chose to merge and those that did not. A variety of metrics are used to examine the performance aspect. It demonstrated that corporations performed better after the merger than they did before.

Keywords: Pre-merger, performance, pharmaceutical industry, globalisation, and economic reforms.